Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular DegenerationDaniel Martín, Frederick L. Ferris, Maureen G. Maguire et al.|Ophthalmology|2012Cited by 1.7k
Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular DegenerationMaureen G. Maguire, Stuart L. Fine, Daniel Martín et al.|Ophthalmology|2016Cited by 702
Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort studyAbraham Olvera‐Barrios, Alicja R. Rudnicka, Christopher G. Owen et al.|BMJ Open Diabetes Research & Care|2023Cited by 12
Two-year recall for people with no diabetic retinopathy: a multi-ethnic population-based retrospective cohort study using real-world data to quantify the effectAbraham Olvera‐Barrios, Christopher G. Owen, Alicja R. Rudnicka et al.|British Journal of Ophthalmology|2023Cited by 10